YATHARTH981.10

Yatharth Hospital & Trauma Care Services Ltd.

· Pharma & Health
AnnualQuarterly₹ CrorePeersMAXHEALTHMEDANTAFORTISVIYASHTHYROCARESUPRIYASTARSPARCMcap ₹9,453 Cr
View
In ₹ Crore except Per Share
12 Months Ending
Q2 FY24
30/09/2023
Q3 FY24
31/12/2023
Q4 FY24
31/03/2024
Q1 FY25
30/06/2024
Q2 FY25
30/09/2024
Q3 FY25
31/12/2024
Q4 FY25
31/03/2025
Q1 FY26
30/06/2025
Q2 FY26
30/09/2025
Q3 FY26
31/12/2025
Q4 FY26
31/03/2026
Q1 FY27
30/06/2026
Revenue from Operations171.3166.8177.8211.8217.8219.2231.8257.8279.4320.5341.6392.7
Other Income3.85.45.73.73.04.25.39.39.57.87.14.4
Total Income175.1172.2183.4215.4220.7223.4237.1267.1288.9328.3348.7397.0
Expenses
+ Cost of Materials Consumed36.031.537.546.843.242.146.553.562.658.40.00.0
+ Purchases of Stock-in-Trade0.00.00.00.00.00.00.00.00.00.057.871.1
+ Changes in Inventories0.00.00.00.00.00.00.00.0-6.24.04.4-1.7
+ Employee Benefit Expense28.429.931.934.641.542.643.848.253.863.570.177.9
+ Finance Costs2.90.20.42.91.62.11.00.20.31.05.16.6
+ Depreciation & Amortisation6.97.97.711.415.916.912.914.918.924.030.028.2
+ Other Expenses61.358.961.976.778.579.684.491.6104.7120.2129.4153.7
Total Expenses135.5128.4139.3172.5180.6183.2188.6208.4234.1271.2296.7335.8
EBITDA45.646.446.553.754.654.957.064.564.574.279.991.7
EBIT38.738.638.842.238.738.044.249.645.650.349.963.4
Profit
PBT before Exceptional Items39.643.844.143.040.140.248.558.754.857.152.061.2
Pretax Income39.643.844.143.040.140.248.558.754.857.152.061.2
+ Current Tax11.714.04.313.610.611.213.814.612.315.111.315.7
+ Deferred Tax0.30.31.5-1.0-1.5-1.5-3.92.01.2-1.1-4.10.1
Tax Expense12.014.35.812.69.19.79.816.613.614.07.315.8
Net Income27.629.538.330.431.030.538.742.041.343.144.745.4
+ Net Income — Continuing Ops27.629.538.330.431.030.538.742.041.343.144.745.4
+ Other Comprehensive Income0.00.00.10.0-0.10.20.2-0.20.20.10.40.1
Total Comprehensive Income27.629.538.530.430.830.738.941.941.443.245.145.6
Net Income to Common0.00.042.041.245.447.1
Minority Interest0.00.00.00.0-2.3-1.6
Per Share
Basic EPS3.803.834.853.543.593.574.374.364.284.714.934.88
Diluted EPS3.803.834.853.543.593.574.374.364.284.714.934.88
Other Comprehensive Income — detail
+ Other Comprehensive Income0.2-0.20.20.10.40.1
+ Items NOT to be Reclassified to P&L-0.10.20.3-0.20.30.20.60.1
+ Tax on Items NOT to be Reclassified0.1-0.10.10.00.10.0
+ Tax on Items NOT to be Reclassified — alt tag0.00.0-0.00.1
Comprehensive Income — Owners of Parent0.00.00.00.00.00.038.941.941.445.547.2
Comprehensive Income — Non-controlling Interests0.00.00.00.00.00.00.00.00.0-2.3-1.6
Per Share — as-filed variants
Basic EPS — Continuing Operations3.803.834.853.543.593.574.374.364.284.714.934.88
Diluted EPS — Continuing Operations3.803.834.853.543.593.574.374.364.284.714.934.88
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit135.2135.3140.3165.0174.6177.1185.3204.3223.0258.0279.4323.3
Gross Margin %78.9581.1078.9277.9080.1880.8179.9479.2479.8280.5181.8082.34
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)39.643.844.143.040.140.248.558.754.857.152.061.2
Net Income Adj (tax-effected)27.629.538.330.431.030.538.742.041.343.144.745.4
EPS Adj3.803.834.853.543.593.574.374.364.284.714.934.88
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value10.0010.0010.0010.000.0010.0010.0010.0010.0010.0010.0010.00
Paid Up Equity Capital8,58,50,233.08,58,50,233.08,58,50,233.08,58,50,233.00.096,35,435.796.496.496.496.496.496.4
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: Q1 FY27 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.